October 2nd 2023
Patients with SARS-CoV-2 infection experienced a 22% increase in the incidence of immune-mediated inflammatory diseases, including T1DM, IBD, and psoriasis.
September 12th 2023
September 12th 2023
September 10th 2023
Community Practice Connections™: 20th Annual Winter Lung Conference
View More
(CME Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment
View More
2nd Annual Hawaii Lung: A Multidisciplinary Case-Based Conference™
Register Now!
Expert Illustrations & Commentaries™: A Closer Look at Emerging Therapies in IBS-C
View More
Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment
View More
Expert Illustrations & Commentaries™: Targeting the Complement System to Optimize Treatment of Cold Agglutinin Disease
View More
2023 Annual Psychiatric Times™ World CME Conference
View More
Community Practice Connections™: Ophthalmology Times® EyeCon 2022
View More
Pharmacist-Led Interventions Can Improve HbA1c in Underserved Communities
September 29th 2023A study from UCLA suggests a pharmacist-led intervention contributed to improved HbA1c in Hispanic adults with type 2 diabetes management, underlining its potential to enhance outcomes in underserved populations.
AI-Powered Smartphone Applications Seen as Promising for Dermatologic Care Use
This new position statement by the Congress of the European Academy of Dermatology and Venereology identified several benefits to the implementation of technological innovations in dermatologic care.
International Group of HS Experts, Patient Research Partners Find Consensus on Evaluation Measures
This set of measures may promote a more accurate assessment of HS in patients as well as on their life outcomes, with the goal being shared decision-making in clinical practice.